CVR Medical Logo
CA1266321084
A2ASKP
CRRVF

CVR Medical

Chargement des cours...

Prévisions

Aucune donnée d'analyste n'est disponible pour cette entreprise.

Discussions dans la communauté

Il n'y a pas encore de discussion sur cet actif.

Lancer une discussion

  • CVR Energy misses Q1 2026 forecasts significantly and reports large net loss

    CVR Energy reported Q1 2026 EPS of -1.24 USD, well below the expected -0.38 USD, while revenue of 1.98 billion USD exceeded estimates. The company recorded a consolidated net loss of 160 million USD and adjusted EBITDA of 37 million USD. Results were hurt by unrealized losses on derivative transactions and high RIN prices; the stock fell 1.58% in premarket trading. For Q2 2026 CVR expects throughput of 200,000–215,000 bpd and direct operating costs of 110–120 million USD; strategic adjustments to the crude slate are intended to improve margins. » Plus sur de.investing.com


  • CVR Energy hits 52-week high and offers high dividend yield

    CVR Energy’s stock rose to $33.25, marking a 52-week high and bringing market capitalization to about $3.33 billion. The yield is 11.49% and the company has paid dividends for 12 consecutive years. Despite a strong price gain of 39.4% over the past year (58.45% in six months), CVR reported an adjusted loss per share of $0.23 in Q2/2025 (expectation: -$0.06), but beat revenue expectations with $1.76 billion. Analyst notes indicate the stock may be trading above its fair value; gross profit margin remained weak at 1.63%. » Plus sur de.investing.com


  • CVR Energy reaches 52-week high at 32.67 USD

    CVR Energy’s stock rose to a 52-week high of 32.67 USD and has gained 70.7% over the past six months; year-to-date the increase is 49.4%. InvestingPro cites a dividend yield of 11.35% and notes 12 consecutive years of dividend payments, but considers the stock to be above its fair value. For Q2 2025 the company reported an adjusted loss per share of 0.23 USD (expectation: -0.06 USD) on revenue of 1.76 billion USD (expectation: 1.68 billion USD), after which the stock fell sharply in after-hours trading. » Plus sur de.investing.com


  • CVRx increases revenue but misses earnings forecast in second quarter 2025

    CVRx grew its revenue by 15% to $13.6 million in the second quarter of 2025, surpassing expectations, but reported a higher net loss of $0.57 per share compared to the forecast of $0.52. The stock saw a slight decline as profitability remains a challenge. The company is maintaining its full-year revenue guidance and is focusing on expanding in the US market and strengthening its sales team. » Plus sur de.investing.com


  • CVRx receives continued Medicare reimbursement for Barostim but lowers revenue forecast

    The Centers for Medicare and Medicaid Services propose to continue reimbursing CVRx's Barostim implantation procedure at around $45,000. Despite this positive regulatory development, CVRx missed revenue expectations in the first quarter and lowered its annual forecast, citing sales challenges. Analysts downgraded the stock due to ongoing uncertainties and volatile revenues. » Plus sur de.investing.com

Données financières de l'entreprise

Au cours de la dernière année, CVR Medical a réalisé un chiffre d'affaires de 0 € et un bénéfice net de -1,58 M €
(EUR) 2021
YoY
Chiffre d'affaires 0 -
Bénéfice brut -215,45 7,54 %
Bénéfice net -1,58 M 1 012,76 %
EBITDA -602,63 k 1 587,74 %

Données fondamentales

Indicateur Valeur
Capitalisation boursière
976,31 €
Nombre d'actions
107,2 M
Plus haut/bas sur 52 semaines
0,0000091 € - 0,0000009 €
Dividendes Non
Bêta
1,82
Ratio P/E
0,00
Ratio PEG
0,00
Ratio P/B
0,00
Ratio P/S
0,00

Profil de l'entreprise

CVR Medical Corp., une entreprise du secteur de la santé, se consacre à la recherche et au développement de technologies d'analyse des ondes sonores subsoniques, infrasoniques et basses fréquences destinées au secteur de la santé. La société propose le dispositif de dépistage des sténoses carotidiennes, un outil de diagnostic permettant de détecter et de mesurer la sténose artérielle carotidienne. Ses produits sont destinés aux patients, aux payeurs et aux prestataires de soins de santé. CVR Medical Corp. a été constituée en 1980 et son siège social se situe à North Vancouver, au Canada.

Nom
CVR Medical
PDG
Darren Day
Siège social North Vancouver, bc
Canada
Site web
Introduction en bourse
02/11/2016
Employés 3

Symboles boursiers

Bourse Symbole
Pnk
CRRVF
London
0UMW.L
München
B3BN.MU
🍪

Parqet  utilise des cookies. En savoir plus